Robert C. Bowen, Chairman and Chief Executive Officer of Scientific Learning, said, “Scientific Learning has established itself as the leader in neuroscience-based products to improve reading and learning based on three decades of research in neuroplasticity. While we will continue to focus our efforts on schools and clinicians who help struggling readers, we are delighted that others are eager to transfer this body of research to practical applications in healthcare so that more can benefit.” Dr. Michael Merzenich, a co-founder of Neuroscience Solutions and Scientific Learning and a member of the National Academy of Sciences, said, “The neuroscience of brain plasticity strongly indicates the forms of special tools that should help remedy or ameliorate a wide variety of neurological and psychiatric problems. Scientific studies documenting the positive neurological impacts of the Fast ForWord family of products along with new, exciting findings in studies of aging have directed us to new strategies to overcome memory and cognitive loss, and to restore more normal posture, balance and mobility in older individuals. “Neuroscience Solutions products should have a significant, positive impact on the quality of life of our aging population. Our goal is to help millions of aging individuals retain high mental and physical abilities to the end of life.” This press release contains projections and other forward-looking statements that are subject to the safe harbor created by Section 27A of the federal securities law. Such statements include, among others, statements relating to the results that may be achieved by products of Scientific Learning and Neuroscience Solutions. Such statements are subject to substantial risks and uncertainties. Actual events or results may differ materially as a result of many factors, including but not limited to: product development obstacles and uncertainties, including but not limited to difficulties related to translating scientific research into commercial products; the companies’ ability to demonstrate the efficacy of their products, which depends on, among other factors, how the programs are implemented and administered, the demography of participants and other factors; and other risks detailed in Scientific Learning’s SEC reports, including but not limited to the Report on Form 10-K filed March 31, 2003 (Part I, Item 1, Factors That May Affect Our Results or Stock Price and Part II, Item 7, Management’s Discussion and Analysis) and the Report on Form 10-Q filed August 14, 2003 (Part I, Item 2, Factors That May Affect Quarterly Results of Operations and Stock Price). About Scientific Learning Corporation Scientific Learning applies advances in neuroscience and cognitive research to increase human potential.
|